Curcuminoids suppress the growth and induce apoptosis through caspase-3-dependent pathways in glioblastoma multiforme

Related Experiment Videos

Tzuu-Yuan Huang1, Tai-Hsin Tsai, Che-Wen Hsu

  • 1Department of Neurosurgery, Tainan Sin-Lau Hospital, Tainan 71101, Taiwan.

Insights

Curcuminoids inhibit human brain glioblastoma cell proliferation and induce apoptosis in a dose-dependent manner. These natural compounds activate apoptosis through mitochondria and caspase pathways, offering potential chemo-preventive effects.

Area of Science:

  • Natural Products Chemistry
  • Cancer Biology
  • Cellular and Molecular Oncology

Background:

  • Curcuminoids, derived from plants, exhibit antioxidant, anti-inflammatory, and chemo-preventive properties.
  • Glioblastoma multiforme (GBM) is an aggressive form of brain cancer with limited treatment options.

Purpose of the Study:

  • To investigate the anti-proliferative and apoptosis-inducing effects of curcuminoids on human glioblastoma multiforme (GBM) 8401 cells.
  • To elucidate the molecular mechanisms underlying curcuminoid-induced apoptosis in GBM cells.

Main Methods:

  • Cell proliferation was assessed using the MTT assay.
  • Apoptosis was analyzed by evaluating mitochondrial membrane potential (ΔΨm), DNA fragmentation, and the activation of caspases (caspase-3, -8, -9) and nuclear factor κB (NF-κB).

Main Results:

  • Curcuminoids demonstrated a dose-dependent inhibition of GBM 8401 cell proliferation.
  • Curcuminoids significantly induced apoptosis in GBM 8401 cells, with effects increasing proportionally to the dose.
  • Apoptosis was mediated through the mitochondrial pathway and involved caspase activation.

Conclusions:

  • Curcuminoids possess significant anti-proliferative and apoptosis-inducing capabilities against human glioblastoma cells.
  • The findings suggest curcuminoids may serve as a potential therapeutic agent for glioblastoma treatment.
  • Further research into curcuminoid-based therapies for brain cancer is warranted.